AddLife AB (publ)

Stockholm Stock Exchange:ALIF-B.ST

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🧬 Biotechnology

💻 Telehealth

Location

Sweden

Market Cap

USD 2.36 B

Share Price

USD 19.39

Avg Daily Volume

186,982

Change (1 day)

-2.76%

Change (1 year)

63.89%

Change (YTD)

56.37%

AddLife AB (publ) Share Price Year-To-Date (YTD) return on June 19, 2025: 56.37%

AddLife AB (publ) Share Price Year-To-Date (YTD) return is 56.37% on June 19, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

AddLife AB (publ) 52-week low Share Price is USD 20.86 on June 19, 2025, which is 7.61% above the current Share Price.
AddLife AB (publ) 52-week low Share Price is USD 11.52 on June 19, 2025, which is -40.59% below the current Share Price.
AddLife AB (publ) average Share Price for the last 52 weeks is USD 14.86.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

Stockholm Stock Exchange: ALIF-B.ST

AddLife AB (publ)

CEO	Mr. Fredrik Dalborg
IPO Date	March 16, 2016
Location	Sweden
Headquarters	Brunkebergstorg 5
Employees	2,251
Sector	🏥 Health Care
Industries Medical Instruments 🧬 Biotechnology 💻 Telehealth

Description

AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.